Brooks Macdonald Asset Management Limited has notified Impact Healthcare REIT PLC of a change in their voting rights. As of 9th February 2024, they hold 5.14% of the voting rights, up from 4.99% previously. This change is attributed to the acquisition of voting rights and is in compliance with the Disclosure Guidance and Transparency Rules. The notification also includes details of the shareholder, Brooks Macdonald Nominees Ltd and Harewood Nominees Ltd, as well as the total number of voting rights held in the issuer, which stands at 21,317,988.
The notification further outlines the breakdown of voting rights, with 5.14% attached to shares directly held by Brooks Macdonald Asset Management Limited. Additionally, it specifies the percentage of voting rights held through financial instruments, which currently stands at 0.00%. The form also includes information about the person subject to the notification obligation, stating that Brooks Macdonald Asset Management Limited is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in the issuer.
Moreover, the notification provides details of the chain of controlled undertakings through which the voting rights and/or financial instruments are effectively held, starting with the ultimate controlling natural person or legal entity. It lists Brooks Macdonald Group PLC and Cornelian Asset Managers Limited, along with their respective percentages of voting rights.
The completion of the notification took place at 21 Lombard Street, London, EC3V 9AH, on 12th February 2024. The document also includes notes regarding the form's reading in conjunction with the applicable Disclosure Guidance and Transparency Rules Chapter 5, as well as the indication of persons who should be mentioned in specific circumstances related to the disclosure of cases of acting in concert.
This notification serves as a formal disclosure of the change in voting rights held by Brooks Macdonald Asset Management Limited in Impact Healthcare REIT PLC, in accordance with regulatory requirements.